Cheryl Gault
Chief Operating Officer chez Rapport Therapeutics, Inc.
Fortune : 2 646 $ au 31/03/2024
Profil
Cheryl Gault is currently the Chief Operating Officer at Rapport Therapeutics, Inc. Her former jobs include being the Head of Sales & Marketing at Genzyme Corp., and the VP of Commercial Strategy & New Product Planning at Ironwood Pharmaceuticals, Inc. from 2017 to 2019.
She was also the Chief Operating Officer at Cyclerion Therapeutics, Inc. from 2021 to 2023.
Ms. Gault received her undergraduate degree from Boston College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/06/2023 | 827 ( 0,03% ) | 2 646 $ | 31/03/2024 |
Postes actifs de Cheryl Gault
| Sociétés | Poste | Début |
|---|---|---|
Rapport Therapeutics, Inc.
 Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. is an American clinical-stage biotechnology company that focuses on discovering and developing medicines for neurological disorders. The CEO of the company is Abraham N. Ceesay. | Chief Operating Officer | 07/09/2023 |
Anciens postes connus de Cheryl Gault
| Sociétés | Poste | Fin |
|---|---|---|
| CYCLERION THERAPEUTICS, INC. | Chief Operating Officer | 28/07/2023 |
| IRONWOOD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/04/2019 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Sales & Marketing | - |
Formation de Cheryl Gault
| Boston College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Health Technology |
| CYCLERION THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Rapport Therapeutics, Inc.
Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. is an American clinical-stage biotechnology company that focuses on discovering and developing medicines for neurological disorders. The CEO of the company is Abraham N. Ceesay. | Health Technology |
